Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | INCB001158 |
| Trade Name | |
| Synonyms | CB-1158|CB1158|CB 1158 |
| Drug Descriptions |
INCB001158 (CB-1158) is a human arginase inhibitor that restores arginine levels in T-cells, thereby promoting T-cell proliferation and anti-tumor immunity (PMID: 32647818). |
| DrugClasses | |
| CAS Registry Number | 2095732-06-0 |
| NCIT ID | C142866 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Cisplatin + Gemcitabine + INCB001158 | Cisplatin Gemcitabine INCB001158 | 0 | 1 |
| Daratumumab + INCB001158 | Daratumumab INCB001158 | 0 | 1 |
| Epacadostat + INCB001158 | Epacadostat INCB001158 | 0 | 1 |
| Epacadostat + INCB001158 + Pembrolizumab | Epacadostat INCB001158 Pembrolizumab | 0 | 1 |
| Fluorouracil + INCB001158 + Leucovorin + Oxaliplatin | Fluorouracil INCB001158 Leucovorin Oxaliplatin | 0 | 1 |
| INCB001158 | INCB001158 | 0 | 1 |
| INCB001158 + Nivolumab | INCB001158 Nivolumab | 0 | 1 |
| INCB001158 + Paclitaxel | INCB001158 Paclitaxel | 0 | 1 |